Moors & Cabot’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $245K | Sell |
1,517
-4,297
| -74% | -$693K | 0.01% | 721 |
|
2025
Q1 | $989K | Sell |
5,814
-5,047
| -46% | -$859K | 0.05% | 324 |
|
2024
Q4 | $1.81M | Buy |
10,861
+1,158
| +12% | +$192K | 0.09% | 201 |
|
2024
Q3 | $1.67M | Buy |
9,703
+374
| +4% | +$64.3K | 0.08% | 217 |
|
2024
Q2 | $1.44M | Buy |
9,329
+595
| +7% | +$91.6K | 0.08% | 230 |
|
2024
Q1 | $1.34M | Buy |
8,734
+365
| +4% | +$56.1K | 0.07% | 240 |
|
2023
Q4 | $1.32M | Buy |
8,369
+314
| +4% | +$49.6K | 0.08% | 234 |
|
2023
Q3 | $1.18M | Buy |
8,055
+264
| +3% | +$38.6K | 0.08% | 226 |
|
2023
Q2 | $1.19M | Sell |
7,791
-81
| -1% | -$12.4K | 0.08% | 240 |
|
2023
Q1 | $1.22M | Sell |
7,872
-41
| -0.5% | -$6.36K | 0.08% | 237 |
|
2022
Q4 | $1.22M | Buy |
7,913
+848
| +12% | +$131K | 0.09% | 237 |
|
2022
Q3 | $932K | Buy |
7,065
+109
| +2% | +$14.4K | 0.07% | 266 |
|
2022
Q2 | $943K | Buy |
6,956
+795
| +13% | +$108K | 0.07% | 283 |
|
2022
Q1 | $919K | Buy |
+6,161
| New | +$919K | 0.06% | 312 |
|
2018
Q2 | – | Sell |
-9,062
| Closed | -$1.2M | – | 569 |
|
2018
Q1 | $1.2M | Buy |
9,062
+1,845
| +26% | +$245K | 0.16% | 156 |
|
2017
Q4 | $896K | Sell |
7,217
-320
| -4% | -$39.7K | 0.12% | 201 |
|
2017
Q3 | $933K | Buy |
7,537
+167
| +2% | +$20.7K | 0.13% | 179 |
|
2017
Q2 | $841K | Buy |
7,370
+3,952
| +116% | +$451K | 0.14% | 186 |
|
2017
Q1 | $361K | Sell |
3,418
-3,195
| -48% | -$337K | 0.06% | 344 |
|
2016
Q4 | $600K | Sell |
6,613
-441
| -6% | -$40K | 0.1% | 244 |
|
2016
Q3 | $703K | Sell |
7,054
-3,299
| -32% | -$329K | 0.12% | 207 |
|
2016
Q2 | $927K | Sell |
10,353
-2,046
| -17% | -$183K | 0.16% | 156 |
|
2016
Q1 | $1.09M | Sell |
12,399
-540
| -4% | -$47.3K | 0.2% | 131 |
|
2015
Q4 | $1.46M | Buy |
+12,939
| New | +$1.46M | 0.27% | 102 |
|